Decibel Therapeutics

$10.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.42 (+4.03%) Today
$0.00 (0.00%) As of 8:28 PM UTC after-hours

Why Robinhood?

You can buy or sell DBTX and other stocks, options, and ETFs commission-free!

About DBTX

Decibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. The firm primarily focuses on hearing disorders, including noise-induced hearing loss; residual hearing preservation or improved sound fidelity with cochlear implants; presbycusis or age-related hearing loss; tinnitus, a persistent ringing in the ears; and genetic hearing loss.

CEO
Laurence E. Reid
Employees
—
Headquarters
Boston, Massachusetts
Founded
2015
Market Cap
265.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
108.57K
High Today
$10.88
Low Today
$10.44
Open Price
$10.48
Volume
33.52K
52 Week High
$24.39
52 Week Low
$10.20

DBTX Earnings

Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

LVTX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure